about
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional StudyJC virus mediates invasion and migration in colorectal metastasis.MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract.IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancerCurcumin modulates DNA methylation in colorectal cancer cells.The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.Colorectal cancers with microsatellite instability display unique miRNA profiles.LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia.MiR-320e is a novel prognostic biomarker in colorectal cancer.Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasisLymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.New genes emerging for colorectal cancer predisposition.Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden.Effect of oral anticoagulants on the outcome of faecal immunochemical test.Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria.Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview.Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancerWhole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancerAccuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies?Risk of cancer in cases of suspected lynch syndrome without germline mutation.Need to implement a coordinated and multidisciplinary care in the Spanish population at increased risk for colorectal cancer.Pitfalls in the diagnosis of biallelic PMS2 mutations.Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.Serrated polyposis syndrome associated with long-standing inflammatory bowel disease.[Hereditary gastric and pancreatic cancer predisposition syndromes].[Hereditary and familial colorectal cancer].Colorectal cancer: serrated polyposis--should we screen first-degree relatives?Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.[Genetics of colorectal cancer].High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.[Intraabdominal desmoid tumors in familial adenomatous polyposis].Association of MUTYH and MSH6 germline mutations in colorectal cancer patients.
P50
Q28551754-504DE528-5398-49DE-9FD6-6B35ECFCB970Q33517629-86BCC197-3C92-47CF-8A80-CB41A03C403CQ33763571-96348FAA-2877-49B3-B3F8-BDD4BDFBF428Q34050656-9E09D0EC-046B-41AF-B679-FE5885263C5FQ34542024-5F571A81-40E7-4BC0-9CF1-D74B75F04B64Q34608782-ECC7271C-895E-46AD-B208-2BD1236C5FE4Q34669614-3D319952-BAB3-44F2-8F1D-9E8C5A2805C5Q35269096-8E95166F-B738-4050-82E5-FFA1C1058348Q35345100-6349A1CD-F34F-4DC0-8FAD-28BDB6A4C33FQ36286673-3F6B3B57-B372-4BBE-82B5-1C4C98995CB7Q36887649-CC0E6D5A-3DFD-479D-A37A-8B94039F325DQ37209436-1FD8091F-4F64-4F81-849E-B8BC344C7F4DQ37587123-2A443CED-4A12-45A6-BF4D-04DB1302D788Q37602721-550DBCAB-2A21-40D5-8D81-0B5DF3870A7BQ37607246-5B722A65-930D-421C-A68D-76D9970ABD4FQ37632165-44A68D03-A335-4822-84B8-7F7F7628B4B8Q38841697-E7AB1610-623B-4A4B-B436-6FC60C390715Q38862392-D6B75D1A-3801-43AC-BA63-C2919A4B8935Q39730089-9E38B159-DACD-45A1-A994-075CDE7009E3Q39778179-B8BC11FF-F4B8-479F-A033-E0536F3FCA16Q39971784-828EB4C8-514F-49AF-9EA9-5EA55089E92DQ40541890-367443B4-ADA4-4D92-B822-253A633D718AQ41492470-A6C66CA4-CDCA-4843-8078-08D0A96FA86BQ41495056-A83A8DD6-5CB6-475E-841B-28D010357765Q41839929-A99EDAA3-543C-4318-8FD1-671B11D7E40CQ42020935-1B69F1F7-A6CC-4246-8CA2-D162F04A0208Q42092391-9E83C4FF-4A40-4269-910E-1517388EE722Q45740719-1307DF8A-9F7A-4636-9E58-F7CAD912DDC6Q47568964-4A4EC64D-B5D4-47CC-AAAA-27A8E22CC3EEQ48279038-0FC369D2-3A3C-4AE7-B18A-A61E023BCD26Q49361827-37123AFD-4459-4B69-B775-726FB54DC207Q50062888-7C23F191-F3FB-4D98-B95F-9990CD22AFF7Q50252625-5C238EE6-9D79-4D52-ADD1-1E036EE9D577Q50458902-FBE6CBE7-B0B2-44C3-B4C1-8E3289171C7EQ50473325-454C30C7-EA34-469E-8FCE-C09B16CBA1C2Q50475473-2A2766A1-D050-449A-898D-843588AECBB7Q50483935-000CF963-1FD0-4376-8DC5-A7472C0A68D8Q50488703-88C75D59-00B1-4C33-A3CA-5A18C8293E1DQ50492996-CC894733-4C87-4AD7-8B9E-57B7572AC595Q50599913-E6B52A22-4B7C-44F0-AF32-BDEFD54B6DE4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francesc Balaguer
@ast
Francesc Balaguer
@en
Francesc Balaguer
@es
Francesc Balaguer
@nl
type
label
Francesc Balaguer
@ast
Francesc Balaguer
@en
Francesc Balaguer
@es
Francesc Balaguer
@nl
prefLabel
Francesc Balaguer
@ast
Francesc Balaguer
@en
Francesc Balaguer
@es
Francesc Balaguer
@nl
P106
P1153
13409831200
P21
P31
P496
0000-0002-0206-0539